Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Prostate Cancer

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    February 2020
  1. FREDSOE J, Koetsenruyter J, Vedsted P, Kirkegaard P, et al
    The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.
    PLoS Med. 2020;17:e1003033.
    PubMed     Text format     Abstract available


    December 2019
  2. CALLENDER T, Emberton M, Morris S, Eeles R, et al
    Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
    PLoS Med. 2019;16:e1002998.
    PubMed     Text format     Abstract available


    October 2019
  3. BJERRE ED, Petersen TH, Jorgensen AB, Johansen C, et al
    Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial.
    PLoS Med. 2019;16:e1002936.
    PubMed     Text format     Abstract available


    July 2019
  4. GROSSET AA, Ouellet V, Caron C, Fragoso G, et al
    Validation of the prognostic value of NF-kappaB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
    PLoS Med. 2019;16:e1002847.
    PubMed     Text format     Abstract available


    June 2019
  5. JAMBOR I, Verho J, Ettala O, Knaapila J, et al
    Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.
    PLoS Med. 2019;16:e1002813.
    PubMed     Text format     Abstract available


    March 2019
  6. THURTLE DR, Greenberg DC, Lee LS, Huang HH, et al
    Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
    PLoS Med. 2019;16:e1002758.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: